Publications by authors named "N Auger"

Introduction: Preeclampsia is associated with acute neurological complications during pregnancy, but the subsequent risk of developing a neurological disorder is unclear. We determined if preeclampsia was associated with the long-term risk of neurological morbidity.

Methods: We conducted a longitudinal cohort study of 1,460,098 pregnant women with and without preeclampsia in Quebec, Canada, between 1989 and 2023.

View Article and Find Full Text PDF
Article Synopsis
  • This study examined how postpartum preeclampsia affects maternal and neonatal outcomes using data from over 1.3 million pregnancies in Quebec from 2006 to 2022.
  • Postpartum preeclampsia was less common than antepartum preeclampsia but was linked to higher risks of preterm birth, placental abruption, and severe maternal complications.
  • The research suggests that women who experience postpartum preeclampsia should have their blood pressure monitored for up to six weeks after delivery to identify any adverse effects.
View Article and Find Full Text PDF
Article Synopsis
  • Next-generation sequencing (NGS) has helped uncover genetic causes of primary ovarian insufficiency (POI), while the reasons for diminished ovarian reserve (DOR) are less understood.
  • A 14-year-old patient with isolated DOR was found to have two frameshift mutations in the BRCA1 gene, but surprisingly showed no signs of Fanconi anemia (FA).
  • Despite the absence of FA symptoms, the patient's cells exhibited high chromosomal fragility, and studies indicated a shortened version of the BRCA1 protein was produced, suggesting that BRCA1 is crucial for ovarian health and functioning.
View Article and Find Full Text PDF

Background Tumor fraction (TF) at liquid biopsy is a potential noninvasive marker for tumor burden, but validation is needed. Purpose To evaluate TF as a potential surrogate for tumor burden, assessed at contrast-enhanced CT across diverse metastatic cancers. Methods This retrospective monocentric study included patients with cancer and metastatic disease, with TF results and contemporaneous contrast-enhanced CT performed between January 2021 and January 2023.

View Article and Find Full Text PDF